HLCMind-Linx contains specifically selected strains of Lactobacillus crispatus (CLT221) and Lactobacillus rhamnosus (CLT341). These are strains that are proven to degrade wheat and dairy exorphins and to attach to, and colonize intestinal epithelial cells (Figures 1 & 2).
Figure 1: Breakdown of milk B-caseomorphin-7 by selected HLC lactic acid bacteria
Figure 2: Breakdown of wheat exorphin-A5 by selected HLC lactic acid bacteria
HLC MindLinx has been shown to degrade dietary exorphins in human subjects (Figures 3).
Figure 3: Effect of 21 days supplementations of HLCMindLinx on urinary excretion of opioid peptide exorphin B5 in six normal adult subjects.>
Subjects were provided with a meal of bread and milk and urinary exorphin measured over the next 10 hours. Subjects took MindLinx for 21 days before being offered the same meal of bread and milk. The difference in the 'before' and 'after' urinary exorphin profiles are clear.
HLC MindLinx contains the original HLC-High Potency specification.
HLC MindLinx provides a total specification of 12 billion cfu's per day.
Note: For further detailed reading, see Technical Monograph entitled 'Intestinal Effects on Autism and ADHD—Potential for a Novel Probiotic Approach'.
Who would benefit?
Any child or adult with autism or ADHD would benefit from HLC MindLinx, especially those with intestinal symptoms of any severity.
Any individual with intolerance to gluten or dairy would derive benefit from HLC-MindLinx.
|
Categories
